Why Diversity Matters in Obesity Clinical Trials Why Diversity Matters in Obesity Clinical Trials Early Career Network, ECN, Education, Upcoming Events, Webinar
Distinguishing Health Promotion from Obesity Prevention: Why Language Matters Distinguishing Health Promotion from Obesity Prevention: Why Language Matters Infographics, Policy, Public Health, Research
ECO2023 NEWSLETTER: DAY FOUR – A toddler’s gut bacteria predict whether they will be overweight at 5 years old ECO2023 NEWSLETTER: DAY FOUR – A toddler’s gut bacteria predict whether they will be overweight at 5 years old ECO
ECO2023 NEWSLETTER: DAY FOUR – Stress hormone measured in hair predicts who is likely to suffer from cardiovascular diseases ECO2023 NEWSLETTER: DAY FOUR – Stress hormone measured in hair predicts who is likely to suffer from cardiovascular diseases ECO
Interview: EASO – Novo Nordisk Foundation New Investigator Award in Childhood Obesity 2023: Dr Cristina Cadenas Sanchez Interview: EASO – Novo Nordisk Foundation New Investigator Award in Childhood Obesity 2023: Dr Cristina Cadenas Sanchez ECO
ECO2023 NEWSLETTER: DAY THREE – Focus on Ireland – Margaret Steele ECO2023 NEWSLETTER: DAY THREE – Focus on Ireland – Margaret Steele ECO
ECO2023 NEWSLETTER: DAY THREE – Media coverage at ECO – summary from Thursday ECO2023 NEWSLETTER: DAY THREE – Media coverage at ECO – summary from Thursday ECO
ECO2023 NEWSLETTER: DAY THREE – Promoting lower-calorie options on delivery apps could help users select healthier options, randomised trials find ECO2023 NEWSLETTER: DAY THREE – Promoting lower-calorie options on delivery apps could help users select healthier options, randomised trials find ECO
ECO2023 NEWSLETTER: DAY THREE – Clinical Research – EASO-Novo Nordisk Foundation New Investigator Award: Sini Heinonen (Finland) ECO2023 NEWSLETTER: DAY THREE – Clinical Research – EASO-Novo Nordisk Foundation New Investigator Award: Sini Heinonen (Finland) ECO
ECO2023 NEWSLETTER: DAY THREE – New analysis shows improved body composition with tirzepatide is consistent across adult age groups with overweight or obesity ECO2023 NEWSLETTER: DAY THREE – New analysis shows improved body composition with tirzepatide is consistent across adult age groups with overweight or obesity ECO
ECO2023 Newsletter Day Two: New communication pathway between fat cells paves way for novel obesity therapies ECO2023 Newsletter Day Two: New communication pathway between fat cells paves way for novel obesity therapies ECO
ECO2023 Newsletter Day Two: Basic Science – EASO-Novo Nordisk Foundation New Investigator Award: Dr Cintia Folgueira Cobos ECO2023 Newsletter Day Two: Basic Science – EASO-Novo Nordisk Foundation New Investigator Award: Dr Cintia Folgueira Cobos ECO
ECO2023 Newsletter Day Two: Nearly half of adolescents using semaglutide in trial dropped below the clinical cutoff for obesity ECO2023 Newsletter Day Two: Nearly half of adolescents using semaglutide in trial dropped below the clinical cutoff for obesity ECO
ECO2023 Newsletter Day Two: Focus on Ireland – Andy Hogan ECO2023 Newsletter Day Two: Focus on Ireland – Andy Hogan ECO
HSE Model of Care for Overweight and Obesity Management HSE Model of Care for Overweight and Obesity Management Research
Important new research identifies cancer-killing benefits of obesity treatment Important new research identifies cancer-killing benefits of obesity treatment Research
English English 
French
